The gut and immune system also depend on microbes
Contraindications Noted in Published Research Because IGF-1 signaling operates through cellular proliferation pathways also implicated in oncogenic processes, the literature consistently identifies active or prior malignancy, and precancerous conditions, as contraindications for IGF-1 LR3 research use
In 2007, Novo Nordisk developed the once-daily drug liraglutide (Victoza for type 2 diabetes and Saxenda for weight management)
Semaglutide belongs to a class of medicines called GLP-1 receptor agonists, which mimic a natural hormone involved in hunger and digestion
Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility
Both berberine and semaglutide are known to cause digestive issues such as nausea, gas, and changes in bowel habits